1. Betschel S, Badiou J, Binkley K, Hébert J, Kanani A, Keith P, et al. Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2014;10:50.
2. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, et al. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Arerugi. 2012;67:147–57.
3. Maurer M, Magerl M, Ansotegui I, Aygören Pürsün E, Betschel S, Bork K, et al. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update. Arerugi. 2018;73:1575–96.
4. Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M, et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Arerugi. 2017;72:300–13.
5. Bork K. Angioedema. Immunol Allergy Clin North Am. 2014;34:23–31.